Option Care Health Inc (OPCH) - Kapitalizatsiyaning foydaga nisbati

Option Care Health Inc - OPCH emitenti grafik logotipi

Logistik muvofiqlik bilan bog'liq qiyinchiliklarga qaramay, Option Care Health (OPCH) kompaniyasining ambulator terapiya sohasidagi yetakchiligi inkor etib bo'lmaydi. GURU.Markets grafigidagi P/E bo'yicha biznes baholash jarayoni shovqinlarni tekislaydi, bunda parametr belgisi 22.30 ga tengdir. Barqarorlik surunkali kasallikka chalingan bemorlar uchun murakkab dori vositalarini boshqarishdan tushadigan daromadlar bilan tasdiqlanadi. Milliy dorixona tarmog'i va logistik miqyos kompaniyaga sug'urta kompaniyalaridan shartnomalarni samarali tarzda yutib olish imkonini beradi.

Option Care Corp - OPCH Narx-foyda koeffitsiyenti (davr: 04.07.2022 - 11.11.2026)

Option Care Health kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari optioncarehealth.com|OPCH - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Option Care Health, Inc.|OPCH - Kompaniyaning to‘liq qiymati
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga xususiy kapital Option Care Health|OPCH - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga multiplikatori optioncarehealth.com|OPCH - Kompaniyaning jami aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning kapitalga nisbati Option Care Health|OPCH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Option Care Corp|OPCH - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Option Care Health, Inc.|OPCH - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Option Care Health|Shoshilinch likvidlik optioncarehealth.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
OPCH - Kompaniyaning sof foydasi|Sof foyda prognozi Option Care Health|OPCH - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Option Care|OPCH - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Option Care Health, Inc.|OPCH - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Option Care Health|OPCH - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi optioncarehealth.com|OPCH - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Option Care Health
Kompaniyaning umumiy tahlili:optioncarehealth.com, OPCH
Option Care original mahsuloti

Option Care Health (OPCH) uy sharoitida infuzion terapiyaga bo'lgan talabning ortishi hisobiga bozor shoklariga qarshi barqarorlikni saqlamoqda, sug'urta kompaniyalari esa stasionar davolash xarajatlarini optimallashtirish uchun ushbu usulni joriy etmoqda. Jori P/E koeffitsiyentini tahlil qilish orqali investorlar emitentning bozor kapitalizatsiyasining uning sof foydasi bilan nisbatiga asoslanib, aktivning qoplash muddati bo'yicha bozor konsensusi va brend uchun haddan tashqari ko'p to'lov qilish xavfini baholaydilar.

Muhim raqobatchilar

Narx-foyda koeffitsiyenti HCA Holdings (HCA)|P/E multiplikatori THC|FMS - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Solventum Inc. SOLV|EHC: Narx-foyda multiplikatori|UHS: Narx-foyda koeffitsiyenti|davita.com - Bozor narxining sof foydaga nisbati|RadNet (RDNT) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Surgery Partners Inc (SGRY)|Narxning foydaga nisbati Premier Corp|America's Best Contacts & Eyeglasses - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti PGNY (Progyny, Inc.)|Bozor narxining sof foydaga nisbati ARDT|P/E multiplikatori SEM (Select Medical Holdings)|Biznesning o‘zini qoplash muddati Astrana Health Inc (ASTH)|MD - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati U.S. Physical Therapy|The Pennant Group, Inc. (PNTG) - Narxning foydaga nisbati|Narx-foyda multiplikatori ORGO|Narx-foyda koeffitsiyenti NUTX|AUNA: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SBC|Narx-foyda koeffitsiyenti Evolus Corp EOLS|P/E multiplikatori CYH (Community Health Systems)|P/E multiplikatori The Beauty Health Company SKIN|MDWD - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati BTMD (Biote)|JYNT: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati DocGo, Inc (DCGO)|Narx-foyda koeffitsiyenti PIII|GANX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EUDA|BMGL (baselmedical.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori CLGN (CollPlant Biotechnologies Ltd.)|Cuprina Holdings Limited (CUPR) - Kapitalizatsiyaning foydaga nisbati|Concord Medical Services - P/E multiplikatori|AMS - P/E multiplikatori|MEDIROM Healthcare Group (MRM) - Narxning foydaga nisbati|ALBT (Avalon GloboCare Corp.) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti DHAI|XAGE (Carmell Corp) - Bozor narxining sof foydaga nisbati|P/E multiplikatori NIVF|ATIP (atipt.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati CareMax CMAX|Kindly MD Inc (KDLY) - Kapitalizatsiyaning foydaga nisbati|MODV - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati NVOS|SSY: P/E multiplikatori|Narx-foyda koeffitsiyenti imacholdings.comm